Fmc Corp Stock Price, News & Analysis

FMC (NYSE:FMC) reported Q3 2025 revenue of $542M, down 49% year-over-year, driven by one-time commercial actions in India as the business is held for sale. Excluding India, revenue was $961M, down 10% versus prior year and 11% organically. GAAP net loss was $569M (loss per diluted share $4.52) after ~$510M of India-related charges and write-downs. Adjusted EBITDA was $236M (+17% YoY) and adjusted EPS was $0.89 (+30% YoY). Full-year guidance was lowered: revenue to $3.92B–$4.02B, Adjusted EBITDA to $830M–$870M, adjusted EPS to $2.92–$3.14, and free cash flow to negative $200M–$0. Quarterly dividend reduced to $0.08 to prioritize debt reduction.

FMC Corporation (NYSE: FMC) has scheduled its third quarter 2025 earnings release for Wednesday, October 29, 2025, after market close. The company will host a webcast conference call the following day, Thursday, October 30, 2025, at 9:00 a.m. ET.

The earnings call will be accessible via internet broadcast and telephone, with both U.S. local and toll-free numbers available. A replay will be available from 11:00 a.m. ET on October 30 until November 6, 2025, through both internet and telephone access.

FMC Corporation (NYSE: FMC) announced that three of its top executives will present at the upcoming Jefferies Industrials Conference. Chairman and CEO Pierre Brondeau, President Ronaldo Pereira, and Executive VP and CFO Andrew Sandifer will speak on September 3, 2025, at 7:30 a.m. ET. Investors can access the live webcast through the company's investor relations website at www.fmc.com/investors.

FMC Corporation (NYSE: FMC) has secured registration for Fundatis® herbicide in Great Britain for winter wheat and winter barley applications. The herbicide, powered by Isoflex® active, is classified as a Group 13 herbicide by HRAC and combines two previously unavailable active ingredients in Great Britain.

Fundatis® herbicide effectively controls key annual grass weeds like Blackgrass and Italian Ryegrass, along with broadleaf weeds such as Groundsel and Speedwell. The product will be available during the fall growing season in Great Britain. Isoflex® active has already been registered in several countries including Argentina, Australia, Brazil, and China, with a pending application in the European Union.

FMC Corporation (NYSE:FMC) reported Q2 2025 results with revenue of $1.05 billion, up 1% year-over-year and 2% organically. The company posted adjusted EBITDA of $207 million (up 2%) and adjusted EPS of $0.69 (up 10%). Notably, FMC announced plans to divest its India commercial business while maintaining manufacturing operations there.

The company maintained its full-year 2025 guidance with adjusted EBITDA of $870-950 million and adjusted EPS of $3.26-3.70. Revenue outlook excluding India is set at $4.08-4.28 billion, down 2% at midpoint versus 2024. Free cash flow forecast remains at $200-400 million, reflecting a 51% decline at midpoint from prior year.

Regional performance varied with EMEA showing strong growth (+29%), while Asia declined (-17%) and North America decreased (-5%). The company's growth portfolio increased by high-single digits.

FMC Corporation (NYSE: FMC) has announced its board of directors has declared a regular quarterly dividend of $0.58 per share. The dividend will be paid on October 16, 2025, to shareholders of record at the close of business on September 30, 2025.

FMC Corporation (NYSE: FMC) has received regulatory approval for Tremisia® fungicide in Ukraine, marking the first introduction of its fluindapyr technology in the EMEA region. The approval covers applications for oilseed rape, sunflower, and wheat across more than 10 million hectares of Ukrainian farmland.

Tremisia® fungicide combines FMC's proprietary fluindapyr molecule with flutriafol, providing a dual mode of action that targets diseases including Alternaria and Sclerotinia in sunflower, and Septoria and rust in wheat. The product has already been successfully commercialized in Argentina, Brazil, Mexico, Paraguay, South Korea, and the United States, with conditional approval in the Philippines.

The company plans to expand the availability of fluindapyr-based products to Bolivia, Chile, Colombia, Honduras, and India, pending regulatory approvals.

FMC Corporation has scheduled its second quarter 2025 earnings release for Wednesday, July 30, 2025, after market close. The company will host a webcast conference call the following day, Thursday, July 31, 2025, at 9:00 a.m. ET. The call will be accessible to the public via internet broadcast and telephone, with both U.S. local and toll-free numbers provided. A replay of the call will be available from 11:00 a.m. ET on July 31 until August 7, 2025, through both internet and telephone access.

FMC Corporation has announced a strategic partnership with Corteva Agriscience to expand the reach of its fluindapyr fungicide technology in U.S. corn and soybean markets. The agreement allows both companies to market fluindapyr-based products, with FMC continuing to offer Adastrio fungicide while developing new products, and Corteva launching its own fluindapyr-based product in early 2026, pending EPA approval. The collaboration targets approximately 175 million planted acres across corn and soybean markets, offering farmers enhanced protection against diseases like tar spot and southern rust. Fluindapyr, a Group 7 fungicide, provides extended residual control and effectively manages pathogen resistance. FMC has already commercialized fluindapyr products in several countries including Argentina, Brazil, and South Korea, with planned launches in Chile, Honduras, India, and Ukraine pending regulatory approval.